Decitabine
PSA Level Greater Than or Equal to Two
Roswell Park Cancer InstituteSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the PSA Level Greater Than or Equal to Two cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin University of Washington | Phase 2 | CCC |
Rucaparib University of Washington | Phase 2 | CCC |
Docetaxel University of Washington | Phase 2 | CCC |
Enzalutamide Roswell Park Cancer Institute | Phase 1/2 | CCC |
Same molecule, other indications
Decitabine is also rated in:
acute myeloid leukemia with t(8;21)(q22;q22) translocationDormant
BB
Indicative ·
70 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →